Business

ACW receives initial $5.5m R&D tax incentive rebate

ACW receives initial $5.5m R&D tax incentive rebate

Actinogen Medical LimitedOctober 14, 20253
ACW receives initial $5.5m R&D tax incentive rebate

About this update from Actinogen Medical Limited

Actinogen Medical Ltd has released a press release. View Attachment

View stock analysis, news, and events for Actinogen Medical Limited

More from Actinogen Medical Limited

All Actinogen Medical Limited news →